Sponsor or institution
Clinical trials and research at Boston Immune Technologies and Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $5.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
BITT-101: a new CD40 blocker for Sjögren’s syndrome
A new therapy called BITT-101 aims to block a key immune signal to help people with Sjögren’s syndrome who currently have limited treatment options.
-
Developing a new treatment for Sjögren’s syndrome using a CD40 antagonist.
This study is looking at a new treatment called BITT-101 for people with Sjögren’s syndrome, which can cause dryness and pain, and it aims to see if this treatment is safe and effective for helping manage your symptoms.
-
New antibody treatment for Non-Hodgkin Lymphoma and a type of skin lymphoma
This project is testing a new antibody treatment, called BITR2101, for people with certain types of cancer, including Non-Hodgkin Lymphoma and Cutaneous T Cell Lymphoma.
-
New treatment targeting cancer cells and their supportive environment in Non-Hodgkin Lymphoma.
This study is testing a new treatment called BITR2101 that targets a specific part of cancer cells to help stop the growth of Non-Hodgkin Lymphoma, especially for those with Cutaneous T Cell Lymphoma, and it may be used on its own or with other therapies to improve patient outcomes.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.